Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Net Margin (2018)

Historic Net Margin for DiaMedica Therapeutics (DMAC) over the last 1 years, with Q3 2018 value amounting to 277.4%.

  • DiaMedica Therapeutics' Net Margin changed N/A to 277.4% in Q3 2018 from the same period last year, while for Jun 2019 it was 1814.0%, marking a year-over-year change of. This contributed to the annual value of 71894.12% for FY2024, which is 162013400.0% down from last year.
  • DiaMedica Therapeutics' Net Margin amounted to 277.4% in Q3 2018.
  • Over the past 5 years, DiaMedica Therapeutics' Net Margin peaked at 277.4% during Q3 2018, and registered a low of 277.4% during Q3 2018.